Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease

被引：0
|
作者：
Volkmann, Elizabeth R. [1 ]
Roth, Michael [1 ]
Elashoff, Robert [2 ]
Clements, Philip J. [1 ]
Furst, Daniel E. [1 ]
Khanna, Dinesh [3 ]
Goldin, Jonathan [4 ]
Tashkin, Donald [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Biomath, Los Angeles, CA 90095 USA
[3] Univ Michigan, Med, Ann Arbor, MI 48109 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1076
引用
收藏
页数：2
相关论文
共 50 条
  • [31] \ Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis-Related Interstitial Lung Disease
    Tiwari, Vivekanand
    Rigby, William F. C.
    ACR OPEN RHEUMATOLOGY, 2022, 4 (02) : 119 - 122
  • [32] The Ambitious Goal of Validating Prognostic Biomarkers for Systemic Sclerosis-related Interstitial Lung Disease
    Bonella, Francesco
    Caramaschi, Paola
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1034 - 1036
  • [33] Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (11) : 2045 - 2056
  • [34] Predicting Mortality in Systemic Sclerosis-Related Interstitial Lung Disease in Two Independent Cohorts
    Tashkin, D. P.
    Volkmann, E.
    Sim, M.
    Roth, M.
    Clements, P.
    Furst, D. E.
    Elashoff, R.
    Keyes-Elstein, L.
    Pinckney, A.
    Goldlmuntz, E.
    Sullivan, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [35] TREATMENT WITH CYCLOPHOSPHAMIDE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE DOES NOT IMPROVE SURVIVAL AFTER 12 YEARS OF FOLLOW UP
    Volkmann, E. R.
    Sim, M.
    Tashkin, D. P.
    Khanna, D.
    Clements, P. J.
    Roth, M.
    Furst, D.
    Pickney, A.
    Goldmuntz, E.
    Keyes-Elstein, L.
    Elashoff, R.
    Sullivan, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 104 - 104
  • [36] A RETROSPECTIVE DESCRIPTIVE ANALYSIS OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AND PULMONARY HYPERTENSION
    Rowe, Anthony
    Ratwani, Ankush
    Barnett, Scott
    King, Christopher
    Shlobin, Oksana
    Nathan, Steven
    CHEST, 2020, 158 (04) : 1878A - 1879A
  • [37] Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
    Panopoulos, Stylianos T.
    Bournia, Vassiliki-Kalliopi
    Trakada, Georgia
    Giavri, Irene
    Kostopoulos, Charalambos
    Sfikakis, Petros P.
    LUNG, 2013, 191 (05) : 483 - 489
  • [38] Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
    Stylianos T. Panopoulos
    Vassiliki-Kalliopi Bournia
    Georgia Trakada
    Irene Giavri
    Charalambos Kostopoulos
    Petros P. Sfikakis
    Lung, 2013, 191 : 483 - 489
  • [39] Occupational Exposures and Systemic Sclerosis-Related Lung Disease
    Volkmann, Elizabeth R.
    CHEST, 2022, 161 (04) : 874 - 875
  • [40] PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER THE LUNG TRANSPLANTATION: A RETROSPECTIVE STUDY
    Nakayama, Y.
    Nakashima, R.
    Handa, T.
    Ohsumi, A.
    Yamada, Y.
    Nakajima, D.
    Yutaka, Y.
    Tanaka, S.
    Hamada, S.
    Ikezoe, K.
    Tanizawa, K.
    Shirakashi, M.
    Hiwa, R.
    Tsuji, H.
    Kitagori, K.
    Akizuki, S.
    Yoshifuji, H.
    Date, H.
    Morinobu, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 160 - 161
12345